Tri Chemical Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Tri Chemical Laboratories has a total shareholder equity of ¥29.8B and total debt of ¥1.5B, which brings its debt-to-equity ratio to 5.2%. Its total assets and total liabilities are ¥38.2B and ¥8.4B respectively. Tri Chemical Laboratories's EBIT is ¥4.1B making its interest coverage ratio 197. It has cash and short-term investments of ¥11.0B.
Key information
5.2%
Debt to equity ratio
JP¥1.54b
Debt
| Interest coverage ratio | 197x |
| Cash | JP¥10.95b |
| Equity | JP¥29.80b |
| Total liabilities | JP¥8.42b |
| Total assets | JP¥38.21b |
Recent financial health updates
Recent updates
Tri Chemical Laboratories' (TSE:4369) Dividend Will Be ¥30.00
Dec 16
Tri Chemical Laboratories' (TSE:4369) Dividend Will Be ¥30.00
Dec 02Tri Chemical Laboratories (TSE:4369) Has Announced A Dividend Of ¥30.00
Nov 13Tri Chemical Laboratories' (TSE:4369) Weak Earnings May Only Reveal A Part Of The Whole Picture
Sep 06Tri Chemical Laboratories Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Sep 03Tri Chemical Laboratories Inc.'s (TSE:4369) 37% Cheaper Price Remains In Tune With Earnings
Aug 05Is Tri Chemical Laboratories (TSE:4369) A Risky Investment?
May 01The Returns On Capital At Tri Chemical Laboratories (TSE:4369) Don't Inspire Confidence
Apr 01Investors Appear Satisfied With Tri Chemical Laboratories Inc.'s (TSE:4369) Prospects As Shares Rocket 30%
Feb 29Estimating The Intrinsic Value Of Tri Chemical Laboratories Inc. (TSE:4369)
Feb 28Financial Position Analysis
Short Term Liabilities: 4369's short term assets (¥23.3B) exceed its short term liabilities (¥7.1B).
Long Term Liabilities: 4369's short term assets (¥23.3B) exceed its long term liabilities (¥1.4B).
Debt to Equity History and Analysis
Debt Level: 4369 has more cash than its total debt.
Reducing Debt: 4369's debt to equity ratio has reduced from 35.4% to 5.2% over the past 5 years.
Debt Coverage: 4369's debt is well covered by operating cash flow (214.5%).
Interest Coverage: 4369's interest payments on its debt are well covered by EBIT (197x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 06:38 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tri Chemical Laboratories Inc. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Niima Komura | BofA Global Research |
| Takeshi Fukuyama | Daiwa Securities Co. Ltd. |
| null null | Daiwa Securities Co. Ltd. |